Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Amy L. Burroughs is the CEO of Terns Pharmaceuticals, Inc., a biotechnology company specializing in the development of innovative treatments for cancer and other serious diseases. Burroughss leadership is characterized by a focus on research excellence, strategic growth, and patient impact. With extensive experience in biotechnology and pharmaceuticals, she has guided Terns Pharmaceuticals through significant advancements in drug development and clinical research. Her commitment to advancing medical science and improving patient outcomes continues to drive Terns Pharmaceuticals success and innovation in the biotech industry.
